Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Over-the-Border Drug Debate Heats to Boiling
When Gov. Rod R. Blagojevich of Illinois announced in mid-September that his state was considering buying drugs from Canada for its employees and citizens, the debate over cross-border drug purchases via the Internet and by other means, got even hotter than it was before. The pharmaceutical industry is fighting a battle similar in scope to the music industry's Internet copyright infringement war, but because no suits have been brought against 80-year-old diabetics buying insulin from pharmacies in Montreal, national debate on the issue of the purchase of foreign drugs has gotten less press of late than the debate over music piracy. Still, for the millions of purchasers of pharmaceutical products and the companies that manufacture and sell them, few subjects are quite as contentious or consequential.
Foreign companies are offering consumers in the United States both Internet and mail-order access to pharmaceutical products, which are often cheaper than U.S. drugs because of government subsidies and price controls. Canadian drugs, for example, are on average 67% less expensive than those sold in the United States. Americans can also easily travel over the Canadian and Mexican borders to buy their pharmaceutical supplies in person, even taking bus trips organized specifically for the drug purchaser. And although Canada is not the only country that provides Americans with access to foreign drugs, Canadian drug companies seem to be the biggest threat to American pharmacies and pharmaceutical manufacturers, largely because of their close proximity to the United States and the trust most Americans have in the safety of Canadian products.
Why So Many Great Lawyers Stink at Business Development and What Law Firms Are Doing About It
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
Bankruptcy Sales: Finding a Diamond In the Rough
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Corporate Enforcement Policy: One Year Later
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
A Lawyer's System for Active Reading
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
Protecting Innovation in the Cyber World from Patent Trolls
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.